• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles

Introduction to 2-(4-amino-3,5-dimethyl-1H-pyrazol-1-yl)ethanol hydrochloride (CAS No: 1224169-47-4)

2-(4-amino-3,5-dimethyl-1H-pyrazol-1-yl)ethanol hydrochloride is a significant compound in the realm of pharmaceutical chemistry, characterized by its unique structural and functional attributes. This compound, identified by the CAS number 1224169-47-4, has garnered considerable attention due to its potential applications in medicinal chemistry and drug development. The molecular structure of this compound incorporates a pyrazole core, which is a heterocyclic aromatic ring system known for its versatility in biological interactions. Specifically, the presence of amino and methyl substituents on the pyrazole ring, along with an ethanol side chain and a hydrochloride salt form, contributes to its distinct chemical properties and reactivity.

The pyrazole moiety in 2-(4-amino-3,5-dimethyl-1H-pyrazol-1-yl)ethanol hydrochloride is a critical feature that underpins its pharmacological relevance. Pyrazole derivatives are widely recognized for their role in various biological processes, including enzyme inhibition and receptor binding. The 3,5-dimethyl substitution pattern enhances the compound's stability and affinity for certain biological targets, making it a valuable scaffold for drug design. Furthermore, the amino group at the 4-position provides a site for further functionalization, enabling the development of more complex derivatives with tailored pharmacological profiles.

Recent advancements in medicinal chemistry have highlighted the importance of hydroxyl-containing compounds in therapeutic applications. The ethanol side chain in 2-(4-amino-3,5-dimethyl-1H-pyrazol-1-yl)ethanol hydrochloride introduces a polar hydroxyl group that can participate in hydrogen bonding interactions. This feature is particularly relevant in drug design, as hydrogen bonding plays a crucial role in molecule-receptor binding affinity and specificity. The hydrochloride salt form of the compound not only enhances its solubility but also modulates its pharmacokinetic properties, making it more suitable for formulation into pharmaceutical products.

Current research in the field of pyrazole derivatives has demonstrated their potential in addressing various therapeutic challenges. For instance, studies have shown that certain pyrazole-based compounds exhibit anti-inflammatory, anticancer, and antimicrobial properties. The structural features of 2-(4-amino-3,5-dimethyl-1H-pyrazol-1-yl)ethanol hydrochloride, including the pyrazole core and substituents, align well with these pharmacological targets. Notably, modifications to the pyrazole ring have been explored to optimize binding interactions with specific enzymes and receptors involved in disease pathways.

The synthesis of 2-(4-amino-3,5-dimethyl-1H-pyrazol-1-yl)ethanol hydrochloride involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. The process typically begins with the preparation of the pyrazole precursor followed by functionalization at the 4-position with an amino group. Subsequent introduction of the ethanol side chain and conversion to the hydrochloride salt form complete the synthesis. Advanced synthetic methodologies, such as catalytic hydrogenation and protecting group strategies, are employed to achieve optimal results.

In terms of biological activity, preliminary studies on 2-(4-amino-3,5-dimethyl-1H-pyrazol-1-yl)ethanol hydrochloride have revealed promising outcomes in vitro. The compound demonstrates interaction with various biological targets, suggesting potential therapeutic utility. For example, it has shown inhibitory effects on certain enzymes implicated in inflammatory responses. Additionally, its ability to modulate receptor activity makes it an attractive candidate for further investigation in drug discovery pipelines.

The development of novel pharmaceutical agents relies heavily on understanding their chemical properties and how they interact with biological systems. The unique structure of 2-(4-amino-3,5-dimethyl-1H-pyrazol-1-yl)ethanol hydrochloride, characterized by its pyrazole core and functional groups, positions it as a versatile building block for designing new drugs. By leveraging computational modeling and high-throughput screening techniques, researchers can rapidly assess the potential of this compound and its derivatives as candidates for clinical development.

As research progresses, the applications of 2-(4-amino-3,5-dimethyl-1H-pyrazol-1-yl)ethanol hydrochloride are expected to expand beyond initial findings. Ongoing studies aim to elucidate its mechanism of action and explore its efficacy in animal models. These efforts will provide valuable insights into its therapeutic potential and guide future development strategies. Collaborative efforts between synthetic chemists and biologists are essential to translate laboratory discoveries into tangible medical benefits.

The significance of hydroxyl-containing intermediates like 2-(4-amino-3,5-dimethyl-1H-pyrazol-1-ylolethanol hydrochloride cannot be overstated in modern drug discovery. Their role as key structural motifs enables the creation of molecules with enhanced pharmacological properties. The combination of diverse substituents on the pyrazole ring allows for fine-tuning of physicochemical characteristics such as solubility, permeability, and metabolic stability—factors critical for successful drug candidates.

In conclusion,2-(4-amino--3,5-dimethyl--1H-pyrazol--1-yl)-ethanol hydrochloride(CAS No: 122<0xE200><0xE000><0xE009><0xE001>) represents a promising compound with significant potential in pharmaceutical research. Its unique structural features and demonstrated biological activity make it a valuable asset in drug development efforts aimed at addressing unmet medical needs.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)